Medical network - on February 4, with the end of the Spring Festival, close to half of the medical device listed companies forecast his performance in 2016. As of February 1 night, already has 23 medical equipment listed company forecast full-year 2016, including 15 net profit year-on-year growth is achieved, accounted for 65.22%.
Medical equipment listed company intensive forecast full-year results
On January 24th January 23 solstice, chutian science and technology, the DE man, dean diagnosis, qianshan mountain medicine machine, YangPu medical, market, Wan Dong has released its 2016 earnings forecast. The six medical equipment listed companies are profitable, the chutian science and technology, dean diagnosis, market and Wan Dong medical 2016 net profit is expected to grow from the same period a year earlier, DE man, machine and qianshan mountain medicine YangPu medical the implementation is reduced.
According to chutian science and technology, according to the announcement is expected to achieve belonging to shareholders of listed companies in 2016 net profit of 153.39 million yuan over the same period of last year, compared to 0-10% growth. Results early increases the main reason is that: (1) the company actively implement the strategy of "a vertical and a horizontal platform" the results of the deployment. During the reporting period, chutian huatong medical equipment co., LTD., sichuan pharmaceutical design institute co., LTD, a subsidiary of good operating performance, and its contribution to net profit of 2016 ownership of the company's common stock shareholders net income of about 35%; (2) in 2016, the company vigorously planning internationalization strategy, and actively expand the international market, export revenues during the reference period year-on-year growth of about 48%, the ratio is about 22% of their revenues; (3) 2016 non-recurring profit and loss impact on net profit amount is about 12.6 million yuan.
At the same time, dean diagnosis, according to preliminary estimates by the financial department, the company is expected to achieve belonging to shareholders of listed companies in 2016 net profit will increase by 30% compared with 2015-60%. , dean of diagnosis growth stems mainly from the denotative expansion and connotative growth, driven by continued companies continue to maintain steady growth, realize the rapid growth of the main business revenue and profit levels steady growth. 2016 non-recurring profit and loss for the company's net profit is expected to affect the amount of about 12 million yuan - 18 million yuan, the basic for the government subsidy project.
Market announcement, according to a preliminary calculation, expect the company earned $2016 in 677.1578 million yuan - 729.2468 million yuan, up 30% from a year ago to 30%. Market, said profit year-on-year growth, mainly because of the company as a whole business medical instrument performance rapid growth plate and medicine plate. In addition, the company will continue to invest in online therapy, lay a foundation for the long-term development of related business sectors. At the same time, along with the continuous expansion of company business, during the reporting period financial expenses have evident rise year-on-year.
In addition, the preliminary estimation by the financial department, Wan Dong medical expects in 2016 annual net profit attributable to shareholders of listed companies $69 million to $71 million, 71-76% compared with a year earlier. The main reason for the increase of current performance is in 2016 the company pay attention to cultivating the brand influence, actively guided by market demand, optimize the structure of each product line product, pay attention to high-end, large investment of equipment and product upgrading, product sales gross profit margin improved effective, reasonable use of idle funds at the same time, increasing the service efficiency of funds led to the growth.
The fall in net profit a year earlier to realize medical apparatus and instruments in the listed company, the DE man expects the company last year net profit of 47.1659 million yuan, 47.1659 million yuan, down 50% from a year earlier - 50%, the main reason is that the company according to the external market changes, adjust sales channels and sales policy; At the same time, we intensified the efforts on marketing, sales cost increase.
Qianshan mountain medicine machine 2016 annual net profit down 20% from a year earlier - 20%, the main reason for the decline are: (1) companies to speed up the health industry layout, the company has expanded rapidly, the slow disease health management project and new medical devices sector investment year-on-year increase in management expenses; (2) new bank loan in financial expenses increase; (3) the company claims to R + E company full provision for asset impairment loss, the net profit attributable to shareholders of listed companies has fallen dramatically. Expect the company non-recurring profit and loss impact on net profit amount during the reporting period is about 7.6451 million yuan.
According to the announcement of YangPu medical, is expected to achieve belonging to shareholders of listed companies in 2016 net profit of 39.8352 million yuan over the same period of last year, compared to fall from 0% to 20%. The main reason for the reduction of performance is: (1) the company bank loans increase from the same period a year earlier, the bank deposit interest rates decrease, lead to financial expenses increase than the same period last year is about 3.07 million yuan. (2) since 2015, the company entered the medical services, the business now in the upfront input stage, has yet to produce economic benefits; (3) to promote the company strategic layout in the global market, constantly introducing overseas innovation, strengthen the overseas sales of existing products at the same time, companies continue to increase investment in U.S. subsidiary, in the United States subsidiary costs increase than the same period last year.
More than sixty percent increase beforehand
According to the incomplete statistics, 43 medical equipment in the listed companies, the existing 23 ushered in a performance in 2016, of which more than sixty percent growth.
Now, the highest increase performance for treasure to Wright, January 16, according to its 2016 annual performance forecast announcement posted, performance year-on-year growth to 180% to 209.98%, which can realize the net profit in 66.973 million yuan - 74.145 million yuan between.
Company said that performance is mainly due to the change during the reporting period, the company's main business revenue growth, at the same time to effectively control cost and expenses. Company's main business income have two plates is better growth, the health monitoring sector revenue growth faster, and kidney disease medical boards sales revenue increased significantly. At the same time the company subsidiary medical plate by increasing efficiency, and innovation model on regional sales, logistics links, reduces production cost effective, these reasons make the net profit attributable to shareholders of listed companies strong growth from a year earlier.
In addition to the treasure to Wright, health sails creatures, CDH innovation, the performance thereof shares by more than 100%.
The slide in the medical device performance of listed companies, in tianjin source in union in the first place, the company in 2016 net profit fell 78.23% year on year. The source in the union says the main reason for the reduction of current performance is: (1) sincere Shanghai biological technology co., LTD., earnings growth, increase the net income of 20.93 million yuan. (2) the company equity (control) and securities investment, compared with the previous year revenue of about 171.16 million yuan. Among them, the securities investment compared with a year earlier gains to reduce 163.16 million yuan; (3) the company set up the U.S. subsidiary of daily operations and development costs, additional cost is about 12.73 million yuan this year.
In addition, the above 23 medical equipment in the listed companies, 2016 average losses. |
